Perinatal and early childhood determinants of disease persistence in PFAPA

Elif Benderlioğlu1, Gülşah Efeoğlu Gülsoy2, Emine Özçelik3

  • 1Department of Pediatrics, Ankara Bilkent City Hospital, 06800, Bilkent, Ankara, Turkey. elifbenderlioglu@gmail.com.

Pediatric Research
|May 16, 2026
PubMed

Insights

Early life factors like preterm birth and pacifier use are linked to a milder course of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA). This helps predict disease persistence and personalize treatment for children with this autoinflammatory condition.

Area of Science:

  • Pediatric Rheumatology
  • Autoinflammatory Diseases
  • Immunology

Background:

  • Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) is a prevalent autoinflammatory condition in children.
  • Understanding factors influencing PFAPA disease course is crucial for effective management.

Purpose of the Study:

  • To investigate the impact of early-life factors on the frequency of attacks and treatment resistance in pediatric PFAPA patients.
  • To identify predictors of persistent versus self-limiting PFAPA phenotypes.

Main Methods:

  • Retrospective evaluation of 81 children diagnosed with PFAPA between April 2021 and 2024.
  • Classification of patients into persistent (less than 50% reduction in attack frequency, post-tonsillectomy, or ongoing attacks beyond age 7) and non-persistent groups.
  • Multivariate analysis to identify independent predictors of disease course.

Main Results:

  • Persistent PFAPA patients experienced more frequent attacks (median 6 vs. 1 per year) but of shorter duration (median 3 vs. 4 days).
  • Preterm birth and pacifier use were significantly less common in the persistent PFAPA group.
  • Abdominal pain, preterm birth, and pacifier use independently predicted a non-persistent (self-limiting) PFAPA course.

Conclusions:

  • Early-life factors, specifically preterm birth and pacifier use, are independently associated with a milder, self-limiting PFAPA phenotype.
  • These findings highlight the role of early immune maturation in PFAPA pathogenesis and offer insights for personalized management and parental counseling.
  • The study provides a novel perspective on autoinflammatory conditions by linking early exposures to disease trajectory.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
Introduction to Language of Pathophysiology ll01:17

Introduction to Language of Pathophysiology ll

This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...